Related Experiment Video
Updated: May 10, 2025

10:14
Retroviral Transduction of T-cell Receptors in Mouse T-cells
Published on: October 22, 2010
34.8K
Memory T Cells: Investigation of Original Models with Transgenic T Cell Receptors
Dmitry B Kazansky1, Anastasiia A Kalinina2, Ludmila M Khromykh2
1N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115522, Russia. kazansky1@yandex.ru.
Biochemistry. Biokhimiia
|April 20, 2025
Summary
Transgenic mouse models reveal T cell receptor (TCR) "chain-centricity," enabling engineered immunity. This discovery offers potential for novel immunotherapies against cancer and infectious diseases by generating specific T cells.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Research on T cell receptor (TCR) function is crucial for understanding immune responses.
- Mouse models are essential tools for studying T lymphocyte homeostasis and activation.
- The laboratory of regulatory mechanisms in immunity has developed novel transgenic mouse models.
Purpose of the Study:
- To summarize research data on original mouse models for studying T lymphocyte homeostasis and activation.
- To investigate new features of immune selection and tumor progression using these models.
- To explore the potential of TCR properties for therapeutic applications.
Main Methods:
- Gene transfer of T cell receptor (TCR) α- and β-chains into mice to create transgenic lines.
- Investigation of immune selection and tumor progression in developed transgenic models.
- Analysis of TCR "chain-centricity" and its implications for T cell recognition.
Main Results:
- Transgenic mouse models were successfully produced, aiding the study of T lymphocyte homeostasis and activation markers.
- The property of TCR "chain-centricity" was confirmed, highlighting the dominance of one TCR chain in MHC/peptide complex recognition.
- Engineered T cells with specific TCRs demonstrated potential for adoptive immunotherapy and innate immunological resistance.
Conclusions:
- TCR structure and specificity play an instructive role in T cell function and phenotype, independent of prior antigen exposure.
- "Chain-centricity" offers a method to generate large pools of immunocompetent T cells for therapeutic use.
- Transgenic models provide valuable insights into immune selection, tumor progression, and the development of targeted immunotherapies.

